| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | TMEM120B SLC24A3 SLC6A15 GRIK3 OTOP3 NDUFA10 MCOLN1 SLC1A7 CALHM4 SLC25A3 SLC8A1 CACNG8 CLCN2 SLC25A13 CNGB3 KCNJ15 LRRC8B ASIC4 CNGA1 CNGA4 MCOLN2 | 6.61e-10 | 793 | 104 | 21 | GO:0015075 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | TMEM120B SLC24A3 GRIK3 OTOP3 MCOLN1 SLC1A7 CALHM4 CACNG8 CLCN2 CNGB3 KCNJ15 LRRC8B ASIC4 CNGA1 CNGA4 MCOLN2 | 1.95e-09 | 459 | 104 | 16 | GO:0005216 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | SLC24A3 SLC6A15 GRIK3 OTOP3 NDUFA10 MCOLN1 SLC1A7 CALHM4 SLC25A3 SLC8A1 CACNG8 SLC25A13 CNGB3 KCNJ15 ASIC4 CNGA1 CNGA4 MCOLN2 | 9.04e-09 | 664 | 104 | 18 | GO:0008324 |
| GeneOntologyMolecularFunction | channel activity | TMEM120B SLC24A3 GRIK3 OTOP3 MCOLN1 SLC1A7 CALHM4 CACNG8 CLCN2 CNGB3 KCNJ15 LRRC8B ASIC4 CNGA1 CNGA4 MCOLN2 | 1.31e-08 | 525 | 104 | 16 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | TMEM120B SLC24A3 GRIK3 OTOP3 MCOLN1 SLC1A7 CALHM4 CACNG8 CLCN2 CNGB3 KCNJ15 LRRC8B ASIC4 CNGA1 CNGA4 MCOLN2 | 1.34e-08 | 526 | 104 | 16 | GO:0022803 |
| GeneOntologyMolecularFunction | transporter activity | TMEM120B XKR8 SLC24A3 SLC6A15 GRIK3 OTOP3 NDUFA10 MCOLN1 SLC1A7 CALHM4 SLC25A3 SLC8A1 CACNG8 CLCN2 SLC25A13 NPC1L1 CNGB3 KCNJ15 LRRC8B ASIC4 ABCC2 CNGA1 CNGA4 MCOLN2 | 3.46e-08 | 1289 | 104 | 24 | GO:0005215 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SLC24A3 SLC6A15 GRIK3 OTOP3 NDUFA10 MCOLN1 SLC1A7 SLC25A3 SLC8A1 CACNG8 CLCN2 SLC25A13 KCNJ15 ASIC4 ABCC2 CNGA1 CNGA4 MCOLN2 | 6.80e-08 | 758 | 104 | 18 | GO:0015318 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | TMEM120B SLC24A3 SLC6A15 GRIK3 OTOP3 NDUFA10 MCOLN1 SLC1A7 CALHM4 SLC25A3 SLC8A1 CACNG8 CLCN2 SLC25A13 CNGB3 KCNJ15 LRRC8B ASIC4 ABCC2 CNGA1 CNGA4 MCOLN2 | 1.41e-07 | 1180 | 104 | 22 | GO:0022857 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | SLC24A3 SLC6A15 GRIK3 OTOP3 NDUFA10 MCOLN1 SLC1A7 SLC25A3 SLC8A1 CACNG8 SLC25A13 KCNJ15 ASIC4 CNGA1 CNGA4 MCOLN2 | 1.51e-07 | 627 | 104 | 16 | GO:0022890 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | SLC24A3 GRIK3 OTOP3 MCOLN1 CALHM4 CACNG8 CNGB3 KCNJ15 ASIC4 CNGA1 CNGA4 MCOLN2 | 2.29e-07 | 343 | 104 | 12 | GO:0005261 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 6.98e-07 | 140 | 104 | 8 | GO:0099094 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 7.35e-07 | 33 | 104 | 5 | GO:0005217 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 7.61e-07 | 193 | 104 | 9 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 9.03e-07 | 197 | 104 | 9 | GO:0022834 | |
| GeneOntologyMolecularFunction | gated channel activity | GRIK3 MCOLN1 SLC1A7 CACNG8 CLCN2 CNGB3 KCNJ15 ASIC4 CNGA1 CNGA4 MCOLN2 | 1.36e-06 | 334 | 104 | 11 | GO:0022836 |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 3.14e-06 | 171 | 104 | 8 | GO:0015081 | |
| GeneOntologyMolecularFunction | intracellularly cGMP-activated cation channel activity | 4.73e-06 | 7 | 104 | 3 | GO:0005223 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | SLC24A3 SLC6A15 GRIK3 MCOLN1 SLC1A7 SLC8A1 CACNG8 KCNJ15 ASIC4 CNGA1 CNGA4 MCOLN2 | 5.49e-06 | 465 | 104 | 12 | GO:0046873 |
| GeneOntologyMolecularFunction | steroid binding | 6.16e-06 | 133 | 104 | 7 | GO:0005496 | |
| GeneOntologyMolecularFunction | retinoic acid binding | 1.29e-05 | 28 | 104 | 4 | GO:0001972 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.42e-05 | 151 | 104 | 7 | GO:0015085 | |
| GeneOntologyMolecularFunction | intracellularly cAMP-activated cation channel activity | 1.60e-05 | 10 | 104 | 3 | GO:0005222 | |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 3.21e-05 | 35 | 104 | 4 | GO:0015020 | |
| GeneOntologyMolecularFunction | intracellularly cyclic nucleotide-activated monoatomic cation channel activity | 3.78e-05 | 13 | 104 | 3 | GO:0005221 | |
| GeneOntologyMolecularFunction | cyclic nucleotide-activated monoatomic ion channel activity | 3.78e-05 | 13 | 104 | 3 | GO:0043855 | |
| GeneOntologyMolecularFunction | calcium channel activity | 5.85e-05 | 129 | 104 | 6 | GO:0005262 | |
| GeneOntologyMolecularFunction | cGMP binding | 7.32e-05 | 16 | 104 | 3 | GO:0030553 | |
| GeneOntologyMolecularFunction | retinoid binding | 1.13e-04 | 48 | 104 | 4 | GO:0005501 | |
| GeneOntologyMolecularFunction | isoprenoid binding | 1.23e-04 | 49 | 104 | 4 | GO:0019840 | |
| GeneOntologyMolecularFunction | sodium channel activity | 1.55e-04 | 52 | 104 | 4 | GO:0005272 | |
| GeneOntologyMolecularFunction | NAADP-sensitive calcium-release channel activity | 2.66e-04 | 5 | 104 | 2 | GO:0072345 | |
| GeneOntologyMolecularFunction | protein kinase C binding | 3.91e-04 | 66 | 104 | 4 | GO:0005080 | |
| GeneOntologyMolecularFunction | fatty acid binding | 4.63e-04 | 69 | 104 | 4 | GO:0005504 | |
| GeneOntologyMolecularFunction | lipid binding | CD300LF UGT1A10 CYP3A43 UGT1A8 UGT1A7 UGT1A9 MCOLN1 MELK LANCL2 AP2A2 STARD9 NPC1L1 HSD11B1 EXOC7 | 6.01e-04 | 988 | 104 | 14 | GO:0008289 |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 8.33e-04 | 211 | 104 | 6 | GO:0016758 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 1.01e-03 | 301 | 104 | 7 | GO:0022853 | |
| GeneOntologyMolecularFunction | cyclic nucleotide binding | 1.09e-03 | 39 | 104 | 3 | GO:0030551 | |
| GeneOntologyMolecularFunction | calcium:sodium antiporter activity | 1.18e-03 | 10 | 104 | 2 | GO:0005432 | |
| GeneOntologyMolecularFunction | neutral L-amino acid transmembrane transporter activity | 1.27e-03 | 41 | 104 | 3 | GO:0015175 | |
| GeneOntologyMolecularFunction | iron ion transmembrane transporter activity | 1.43e-03 | 11 | 104 | 2 | GO:0005381 | |
| GeneOntologyMolecularFunction | aminopeptidase activity | 1.46e-03 | 43 | 104 | 3 | GO:0004177 | |
| GeneOntologyMolecularFunction | co-SMAD binding | 1.71e-03 | 12 | 104 | 2 | GO:0070410 | |
| GeneOntologyMolecularFunction | calcium:monoatomic cation antiporter activity | 2.02e-03 | 13 | 104 | 2 | GO:0015368 | |
| GeneOntologyMolecularFunction | monoatomic anion channel activity | 2.07e-03 | 103 | 104 | 4 | GO:0005253 | |
| GeneOntologyMolecularFunction | guanyl ribonucleotide binding | 2.10e-03 | 439 | 104 | 8 | GO:0032561 | |
| GeneOntologyMolecularFunction | guanyl nucleotide binding | 2.10e-03 | 439 | 104 | 8 | GO:0019001 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 2.22e-03 | 105 | 104 | 4 | GO:0015171 | |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 2.38e-03 | 107 | 104 | 4 | GO:0033293 | |
| GeneOntologyMolecularFunction | L-glutamate transmembrane transporter activity | 2.70e-03 | 15 | 104 | 2 | GO:0005313 | |
| GeneOntologyMolecularFunction | protein homodimerization activity | DPP4 PDGFRA UGT1A10 UGT1A8 UGT1A7 RIPK2 UGT1A9 ADD2 JUP NPC1L1 HSD11B1 | 3.46e-03 | 815 | 104 | 11 | GO:0042803 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC24A3 SLC6A15 NDUFA10 SLC1A7 SLC25A3 SLC8A1 SLC25A13 ABCC2 | 3.48e-03 | 477 | 104 | 8 | GO:0022804 |
| GeneOntologyMolecularFunction | ligand-gated sodium channel activity | 3.89e-03 | 18 | 104 | 2 | GO:0015280 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 3.89e-03 | 18 | 104 | 2 | GO:0015278 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | 3.98e-03 | 288 | 104 | 6 | GO:0016757 | |
| GeneOntologyMolecularFunction | kinase binding | UGT1A10 UGT1A8 UGT1A7 UGT1A9 PFKFB1 ADD2 JUP AP2A2 TBC1D14 LRBA MAPK6 HTT | 4.53e-03 | 969 | 104 | 12 | GO:0019900 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 4.55e-03 | 296 | 104 | 6 | GO:0015291 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 4.58e-03 | 207 | 104 | 5 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 4.67e-03 | 208 | 104 | 5 | GO:0005342 | |
| GeneOntologyMolecularFunction | acidic amino acid transmembrane transporter activity | 4.80e-03 | 20 | 104 | 2 | GO:0015172 | |
| GeneOntologyMolecularFunction | amino acid:sodium symporter activity | 6.33e-03 | 23 | 104 | 2 | GO:0005283 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 7.00e-03 | 145 | 104 | 4 | GO:0004713 | |
| GeneOntologyMolecularFunction | cAMP binding | 7.45e-03 | 25 | 104 | 2 | GO:0030552 | |
| GeneOntologyMolecularFunction | symporter activity | 7.87e-03 | 150 | 104 | 4 | GO:0015293 | |
| GeneOntologyMolecularFunction | metalloaminopeptidase activity | 8.05e-03 | 26 | 104 | 2 | GO:0070006 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 8.06e-03 | 151 | 104 | 4 | GO:0008509 | |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | 8.43e-03 | 153 | 104 | 4 | GO:0008194 | |
| GeneOntologyMolecularFunction | ubiquitin-like ligase-substrate adaptor activity | 9.03e-03 | 82 | 104 | 3 | GO:1990756 | |
| GeneOntologyMolecularFunction | mannosyltransferase activity | 9.30e-03 | 28 | 104 | 2 | GO:0000030 | |
| GeneOntologyMolecularFunction | amino acid:monoatomic cation symporter activity | 9.95e-03 | 29 | 104 | 2 | GO:0005416 | |
| GeneOntologyMolecularFunction | virus receptor activity | 9.95e-03 | 85 | 104 | 3 | GO:0001618 | |
| GeneOntologyMolecularFunction | exogenous protein binding | 1.03e-02 | 86 | 104 | 3 | GO:0140272 | |
| GeneOntologyBiologicalProcess | estrogen catabolic process | 3.16e-09 | 5 | 105 | 4 | GO:0006711 | |
| GeneOntologyBiologicalProcess | phenylpropanoid catabolic process | 9.44e-09 | 6 | 105 | 4 | GO:0046271 | |
| GeneOntologyBiologicalProcess | coumarin catabolic process | 9.44e-09 | 6 | 105 | 4 | GO:0046226 | |
| GeneOntologyBiologicalProcess | flavone metabolic process | 9.44e-09 | 6 | 105 | 4 | GO:0051552 | |
| GeneOntologyBiologicalProcess | steroid catabolic process | 1.80e-08 | 34 | 105 | 6 | GO:0006706 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | ATP6AP1 SLC24A3 SLC6A15 GRIK3 OTOP3 MCOLN1 SLC1A7 CALHM4 SLC25A3 SLC8A1 CACNG8 CLCN2 SLC25A13 CNGB3 KCNJ15 LRRC8B ASIC4 ABCC2 CNGA1 CNGA4 HTT MCOLN2 | 3.57e-08 | 1115 | 105 | 22 | GO:0034220 |
| GeneOntologyBiologicalProcess | hormone catabolic process | 5.92e-08 | 21 | 105 | 5 | GO:0042447 | |
| GeneOntologyBiologicalProcess | phenylpropanoid metabolic process | 1.30e-07 | 10 | 105 | 4 | GO:0009698 | |
| GeneOntologyBiologicalProcess | coumarin metabolic process | 1.30e-07 | 10 | 105 | 4 | GO:0009804 | |
| GeneOntologyBiologicalProcess | hormone metabolic process | DPP4 PDGFRA UGT1A10 CYP3A43 UGT1A8 UGT1A7 UGT1A9 CLCN2 HSD17B6 HSD11B1 HTT | 2.36e-07 | 286 | 105 | 11 | GO:0042445 |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 2.54e-07 | 52 | 105 | 6 | GO:0008210 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | ATP6AP1 SLC24A3 SLC6A15 GRIK3 OTOP3 MCOLN1 SLC1A7 CALHM4 ADD2 SLC25A3 SLC8A1 CACNG8 CLCN2 SLC25A13 CNGB3 KCNJ15 LRRC8B ASIC4 ABCC2 CNGA1 CNGA4 HTT MCOLN2 | 3.23e-07 | 1374 | 105 | 23 | GO:0006811 |
| GeneOntologyBiologicalProcess | flavonoid metabolic process | 4.38e-07 | 13 | 105 | 4 | GO:0009812 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | ATP6AP1 SLC24A3 SLC6A15 OTOP3 MCOLN1 CALHM4 SLC25A3 SLC8A1 CACNG8 SLC25A13 CNGB3 KCNJ15 ASIC4 ABCC2 CNGA1 CNGA4 HTT MCOLN2 | 1.19e-06 | 942 | 105 | 18 | GO:0098655 |
| GeneOntologyBiologicalProcess | flavonoid glucuronidation | 1.27e-06 | 5 | 105 | 3 | GO:0052696 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | ATP6AP1 SLC24A3 SLC6A15 OTOP3 MCOLN1 SLC1A7 SLC25A3 SLC8A1 CACNG8 CLCN2 SLC25A13 KCNJ15 ASIC4 ABCC2 CNGA1 CNGA4 HTT MCOLN2 | 3.51e-06 | 1017 | 105 | 18 | GO:0098660 |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 3.55e-06 | 21 | 105 | 4 | GO:0052695 | |
| GeneOntologyBiologicalProcess | cellular catabolic process | LVRN TSPAN15 ADCY10 KAT5 ANPEP VPS13C CYP3A43 RIPK2 PFKFB1 ADTRP MCOLN1 TECPR2 SMPDL3A HSD17B6 TBC1D14 ATM LRBA ABCC2 EXOC7 HTT | 4.48e-06 | 1253 | 105 | 20 | GO:0044248 |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 8.70e-06 | 26 | 105 | 4 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 8.70e-06 | 26 | 105 | 4 | GO:0006063 | |
| GeneOntologyBiologicalProcess | isoprenoid metabolic process | 8.98e-06 | 144 | 105 | 7 | GO:0006720 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | ATP6AP1 SLC24A3 SLC6A15 OTOP3 MCOLN1 SLC25A3 SLC8A1 CACNG8 SLC25A13 KCNJ15 ASIC4 ABCC2 CNGA1 CNGA4 HTT MCOLN2 | 1.67e-05 | 922 | 105 | 16 | GO:0098662 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | ATP6AP1 SLC24A3 SLC6A15 OTOP3 MCOLN1 CALHM4 SLC25A3 SLC8A1 CACNG8 SLC25A13 CNGB3 KCNJ15 ASIC4 ABCC2 CNGA1 CNGA4 HTT MCOLN2 | 2.04e-05 | 1157 | 105 | 18 | GO:0006812 |
| GeneOntologyBiologicalProcess | macroautophagy | 2.13e-05 | 374 | 105 | 10 | GO:0016236 | |
| GeneOntologyBiologicalProcess | steroid metabolic process | PDGFRA UGT1A10 CYP3A43 UGT1A8 UGT1A7 UGT1A9 CLCN2 HSD17B6 NPC1L1 HSD11B1 | 2.23e-05 | 376 | 105 | 10 | GO:0008202 |
| GeneOntologyBiologicalProcess | secondary metabolic process | 2.33e-05 | 67 | 105 | 5 | GO:0019748 | |
| GeneOntologyBiologicalProcess | xenobiotic glucuronidation | 2.73e-05 | 12 | 105 | 3 | GO:0052697 | |
| GeneOntologyBiologicalProcess | regulation of hormone levels | DPP4 PDGFRA UGT1A10 CYP3A43 UGT1A8 UGT1A7 TM7SF3 UGT1A9 CLCN2 HSD17B6 HSD11B1 ABCC2 HTT | 4.43e-05 | 684 | 105 | 13 | GO:0010817 |
| GeneOntologyBiologicalProcess | retinoic acid metabolic process | 5.03e-05 | 40 | 105 | 4 | GO:0042573 | |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 8.47e-05 | 141 | 105 | 6 | GO:0006805 | |
| GeneOntologyBiologicalProcess | retinoid metabolic process | 9.18e-05 | 89 | 105 | 5 | GO:0001523 | |
| GeneOntologyBiologicalProcess | pigment metabolic process | 1.19e-04 | 94 | 105 | 5 | GO:0042440 | |
| GeneOntologyBiologicalProcess | diterpenoid metabolic process | 1.19e-04 | 94 | 105 | 5 | GO:0016101 | |
| GeneOntologyBiologicalProcess | calcium ion export | 1.53e-04 | 4 | 105 | 2 | GO:1901660 | |
| GeneOntologyBiologicalProcess | positive regulation of TORC2 signaling | 1.53e-04 | 4 | 105 | 2 | GO:1904515 | |
| GeneOntologyBiologicalProcess | terpenoid metabolic process | 2.00e-04 | 105 | 105 | 5 | GO:0006721 | |
| GeneOntologyBiologicalProcess | microtubule-based transport | 3.15e-04 | 253 | 105 | 7 | GO:0099111 | |
| GeneOntologyBiologicalProcess | positive regulation of aggrephagy | 3.80e-04 | 6 | 105 | 2 | GO:1905337 | |
| GeneOntologyBiologicalProcess | regulation of macroautophagy | 3.81e-04 | 186 | 105 | 6 | GO:0016241 | |
| GeneOntologyBiologicalProcess | process utilizing autophagic mechanism | ADCY10 KAT5 VPS13C RIPK2 MCOLN1 TECPR2 TBC1D14 ATM LRBA EXOC7 HTT | 4.76e-04 | 650 | 105 | 11 | GO:0061919 |
| GeneOntologyBiologicalProcess | autophagy | ADCY10 KAT5 VPS13C RIPK2 MCOLN1 TECPR2 TBC1D14 ATM LRBA EXOC7 HTT | 4.76e-04 | 650 | 105 | 11 | GO:0006914 |
| GeneOntologyBiologicalProcess | sodium ion transport | 5.19e-04 | 275 | 105 | 7 | GO:0006814 | |
| GeneOntologyBiologicalProcess | regulation of TORC2 signaling | 5.30e-04 | 7 | 105 | 2 | GO:1903939 | |
| GeneOntologyBiologicalProcess | mitophagy | 5.84e-04 | 75 | 105 | 4 | GO:0000423 | |
| GeneOntologyBiologicalProcess | mitochondrial transport | 6.37e-04 | 205 | 105 | 6 | GO:0006839 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 6.88e-04 | 208 | 105 | 6 | GO:0035725 | |
| GeneOntologyBiologicalProcess | regulation of aggrephagy | 7.05e-04 | 8 | 105 | 2 | GO:1905335 | |
| GeneOntologyBiologicalProcess | lipid catabolic process | 7.52e-04 | 382 | 105 | 8 | GO:0016042 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | 8.89e-04 | 392 | 105 | 8 | GO:0070588 | |
| GeneOntologyBiologicalProcess | photoreceptor cell morphogenesis | 9.03e-04 | 9 | 105 | 2 | GO:0008594 | |
| GeneOntologyBiologicalProcess | microtubule-based movement | 9.35e-04 | 493 | 105 | 9 | GO:0007018 | |
| GeneOntologyBiologicalProcess | regulation of mitophagy | 9.50e-04 | 38 | 105 | 3 | GO:1901524 | |
| GeneOntologyBiologicalProcess | cellular response to xenobiotic stimulus | 9.64e-04 | 222 | 105 | 6 | GO:0071466 | |
| GeneOntologyCellularComponent | intracellular cyclic nucleotide activated cation channel complex | 4.25e-06 | 7 | 105 | 3 | GO:0017071 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | DPY19L3 ATP6AP1 PDGFRA MBOAT7 UGT1A10 VPS13C CYP3A43 UGT1A8 UGT1A7 DOLK UGT1A9 SCD5 PIGT ALG9 AGMO LRRC8B HSD11B1 LRBA | 7.33e-05 | 1293 | 105 | 18 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | DPY19L3 ATP6AP1 PDGFRA MBOAT7 UGT1A10 VPS13C CYP3A43 UGT1A8 UGT1A7 DOLK UGT1A9 SCD5 PIGT ALG9 AGMO LRRC8B HSD11B1 LRBA | 7.77e-05 | 1299 | 105 | 18 | GO:0098827 |
| GeneOntologyCellularComponent | Cul2-RING ubiquitin ligase complex | 9.08e-05 | 47 | 105 | 4 | GO:0031462 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | DPY19L3 ATP6AP1 PDGFRA MBOAT7 UGT1A10 VPS13C CYP3A43 UGT1A8 UGT1A7 DOLK UGT1A9 SCD5 PIGT ALG9 AGMO LRRC8B HSD11B1 LRBA | 1.02e-04 | 1327 | 105 | 18 | GO:0042175 |
| GeneOntologyCellularComponent | lysosomal membrane | DPP4 ATP6AP1 ANPEP VPS13C TASL MCOLN1 WDR59 AP2A2 LRBA MCOLN2 | 1.12e-04 | 462 | 105 | 10 | GO:0005765 |
| GeneOntologyCellularComponent | lytic vacuole membrane | DPP4 ATP6AP1 ANPEP VPS13C TASL MCOLN1 WDR59 AP2A2 LRBA MCOLN2 | 1.12e-04 | 462 | 105 | 10 | GO:0098852 |
| GeneOntologyCellularComponent | vacuole | DPP4 ATP6AP1 ANPEP VPS13C KERA TASL MCOLN1 WDR59 DNASE2B AP2A2 TBC1D14 LRBA HTT MCOLN2 | 1.89e-04 | 913 | 105 | 14 | GO:0005773 |
| GeneOntologyCellularComponent | vacuolar membrane | DPP4 ATP6AP1 ANPEP VPS13C TASL MCOLN1 WDR59 AP2A2 LRBA MCOLN2 | 2.37e-04 | 507 | 105 | 10 | GO:0005774 |
| GeneOntologyCellularComponent | transmembrane transporter complex | ATP6AP1 GRIK3 NDUFA10 CACNG8 CLCN2 CNGB3 KCNJ15 LRRC8B CNGA1 CNGA4 | 3.04e-04 | 523 | 105 | 10 | GO:1902495 |
| GeneOntologyCellularComponent | cell projection membrane | 3.25e-04 | 431 | 105 | 9 | GO:0031253 | |
| GeneOntologyCellularComponent | transporter complex | ATP6AP1 GRIK3 NDUFA10 CACNG8 CLCN2 CNGB3 KCNJ15 LRRC8B CNGA1 CNGA4 | 4.51e-04 | 550 | 105 | 10 | GO:1990351 |
| GeneOntologyCellularComponent | cilium | ADCY10 PDGFRA USP9X PRAMEF15 CFAP54 RABL2B RABL2A GPR157 CNGB3 TAS2R50 DNAH5 CNGA1 CNGA4 | 5.62e-04 | 898 | 105 | 13 | GO:0005929 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 6.44e-04 | 378 | 105 | 8 | GO:0034702 | |
| GeneOntologyCellularComponent | lysosome | DPP4 ATP6AP1 ANPEP VPS13C KERA TASL MCOLN1 WDR59 DNASE2B AP2A2 LRBA MCOLN2 | 7.66e-04 | 811 | 105 | 12 | GO:0005764 |
| GeneOntologyCellularComponent | lytic vacuole | DPP4 ATP6AP1 ANPEP VPS13C KERA TASL MCOLN1 WDR59 DNASE2B AP2A2 LRBA MCOLN2 | 7.66e-04 | 811 | 105 | 12 | GO:0000323 |
| GeneOntologyCellularComponent | intercellular canaliculus | 8.79e-04 | 9 | 105 | 2 | GO:0046581 | |
| GeneOntologyCellularComponent | SCAR complex | 1.60e-03 | 12 | 105 | 2 | GO:0031209 | |
| GeneOntologyCellularComponent | astrocyte end-foot | 1.60e-03 | 12 | 105 | 2 | GO:0097450 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | TSPAN15 ATP6AP1 ANPEP VPS13C TASL MCOLN1 CACNG8 AP2A2 HSD17B6 NPC1L1 ATM CNGA4 HTT MCOLN2 NCKAP1L | 2.22e-03 | 1307 | 105 | 15 | GO:0030659 |
| GeneOntologyCellularComponent | vesicle membrane | TSPAN15 ATP6AP1 ANPEP VPS13C TASL MCOLN1 CACNG8 AP2A2 HSD17B6 NPC1L1 ATM CNGA4 HTT MCOLN2 NCKAP1L | 2.53e-03 | 1325 | 105 | 15 | GO:0012506 |
| Domain | ARM-like | 2.44e-06 | 270 | 103 | 10 | IPR011989 | |
| Domain | UDPGT | 4.86e-06 | 21 | 103 | 4 | PF00201 | |
| Domain | UDPGT | 4.86e-06 | 21 | 103 | 4 | PS00375 | |
| Domain | UDP_glucos_trans | 4.86e-06 | 21 | 103 | 4 | IPR002213 | |
| Domain | ARM-type_fold | 1.80e-05 | 339 | 103 | 10 | IPR016024 | |
| Domain | Mt_Rho_GTPase | 3.01e-05 | 2 | 103 | 2 | IPR021181 | |
| Domain | EF_assoc_2 | 3.01e-05 | 2 | 103 | 2 | PF08356 | |
| Domain | EF_assoc_1 | 3.01e-05 | 2 | 103 | 2 | PF08355 | |
| Domain | EF_hand_assoc_2 | 3.01e-05 | 2 | 103 | 2 | IPR013567 | |
| Domain | EF_hand_assoc_1 | 3.01e-05 | 2 | 103 | 2 | IPR013566 | |
| Domain | Nck-associated_protein-1 | 3.01e-05 | 2 | 103 | 2 | IPR019137 | |
| Domain | MIRO_dom | 3.01e-05 | 2 | 103 | 2 | IPR020860 | |
| Domain | MIRO | 3.01e-05 | 2 | 103 | 2 | PS51423 | |
| Domain | Nckap1 | 3.01e-05 | 2 | 103 | 2 | PF09735 | |
| Domain | cNMP-bd_CS | 8.66e-05 | 16 | 103 | 3 | IPR018488 | |
| Domain | CLZ_dom | 1.79e-04 | 4 | 103 | 2 | IPR032406 | |
| Domain | CLZ | 1.79e-04 | 4 | 103 | 2 | PF16526 | |
| Domain | - | 2.30e-04 | 222 | 103 | 7 | 1.25.10.10 | |
| Domain | Ion_trans_dom | 4.22e-04 | 114 | 103 | 5 | IPR005821 | |
| Domain | Ion_trans | 4.22e-04 | 114 | 103 | 5 | PF00520 | |
| Domain | CNMP_BINDING_1 | 7.19e-04 | 32 | 103 | 3 | PS00888 | |
| Domain | CNMP_BINDING_2 | 7.19e-04 | 32 | 103 | 3 | PS00889 | |
| Domain | ERAP1-like_C_dom | 8.25e-04 | 8 | 103 | 2 | IPR024571 | |
| Domain | ERAP1_C | 8.25e-04 | 8 | 103 | 2 | PF11838 | |
| Domain | cNMP | 8.61e-04 | 34 | 103 | 3 | SM00100 | |
| Domain | cNMP_binding | 8.61e-04 | 34 | 103 | 3 | PF00027 | |
| Domain | cNMP-bd_dom | 9.38e-04 | 35 | 103 | 3 | IPR000595 | |
| Domain | CNMP_BINDING_3 | 9.38e-04 | 35 | 103 | 3 | PS50042 | |
| Domain | NaCa_Exmemb | 1.06e-03 | 9 | 103 | 2 | IPR004837 | |
| Domain | Na_Ca_ex | 1.06e-03 | 9 | 103 | 2 | PF01699 | |
| Domain | cNMP-bd-like | 1.19e-03 | 38 | 103 | 3 | IPR018490 | |
| Domain | PKD_channel | 1.60e-03 | 11 | 103 | 2 | PF08016 | |
| Domain | DOCK_C | 1.60e-03 | 11 | 103 | 2 | IPR010703 | |
| Domain | DHR-1_domain | 1.60e-03 | 11 | 103 | 2 | IPR027007 | |
| Domain | DHR_2 | 1.60e-03 | 11 | 103 | 2 | PS51651 | |
| Domain | DHR_1 | 1.60e-03 | 11 | 103 | 2 | PS51650 | |
| Domain | DOCK-C2 | 1.60e-03 | 11 | 103 | 2 | PF14429 | |
| Domain | DHR-2 | 1.60e-03 | 11 | 103 | 2 | IPR027357 | |
| Domain | DHR-2 | 1.60e-03 | 11 | 103 | 2 | PF06920 | |
| Domain | DOCK | 1.60e-03 | 11 | 103 | 2 | IPR026791 | |
| Domain | PKD1_2_channel | 1.60e-03 | 11 | 103 | 2 | IPR013122 | |
| Domain | Peptidase_M1 | 1.92e-03 | 12 | 103 | 2 | IPR001930 | |
| Domain | Roc | 2.26e-03 | 13 | 103 | 2 | PF08477 | |
| Domain | MIRO-like | 2.26e-03 | 13 | 103 | 2 | IPR013684 | |
| Domain | Peptidase_M1 | 2.26e-03 | 13 | 103 | 2 | PF01433 | |
| Domain | Peptidase_M1_N | 2.26e-03 | 13 | 103 | 2 | IPR014782 | |
| Domain | - | 2.35e-03 | 48 | 103 | 3 | 2.60.120.10 | |
| Domain | RmlC-like_jellyroll | 2.80e-03 | 51 | 103 | 3 | IPR014710 | |
| Domain | PRAME_family | 4.84e-03 | 19 | 103 | 2 | IPR026271 | |
| Domain | Ras | 6.82e-03 | 136 | 103 | 4 | PF00071 | |
| Domain | P-loop_NTPase | ADCY10 RHOT2 PFKFB1 NDUFA10 RABL2B RABL2A STARD9 ASPM ABCC2 DNAH5 RHOT1 | 7.05e-03 | 848 | 103 | 11 | IPR027417 |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 1.36e-08 | 55 | 74 | 7 | M14933 | |
| Pathway | REACTOME_ASPIRIN_ADME | 1.18e-07 | 45 | 74 | 6 | MM15694 | |
| Pathway | WP_CODEINE_AND_MORPHINE_METABOLISM | 6.73e-07 | 14 | 74 | 4 | M39328 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 1.74e-06 | 39 | 74 | 5 | MM15695 | |
| Pathway | REACTOME_DRUG_ADME | 2.88e-06 | 119 | 74 | 7 | MM15692 | |
| Pathway | WP_ESTROGEN_METABOLISM | 4.76e-06 | 22 | 74 | 4 | MM15888 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 6.76e-06 | 51 | 74 | 5 | M17726 | |
| Pathway | REACTOME_GLUCURONIDATION | 6.87e-06 | 24 | 74 | 4 | MM14599 | |
| Pathway | REACTOME_GLUCURONIDATION | 8.14e-06 | 25 | 74 | 4 | M17787 | |
| Pathway | WP_GLUCURONIDATION | 8.14e-06 | 25 | 74 | 4 | MM15820 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 8.14e-06 | 25 | 74 | 4 | M605 | |
| Pathway | WP_GLUCURONIDATION | 9.58e-06 | 26 | 74 | 4 | M39404 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 1.30e-05 | 28 | 74 | 4 | M19580 | |
| Pathway | KEGG_RETINOL_METABOLISM | 2.08e-05 | 64 | 74 | 5 | M9488 | |
| Pathway | REACTOME_DRUG_ADME | 2.25e-05 | 109 | 74 | 6 | M45012 | |
| Pathway | WP_IRINOTECAN_PATHWAY | 2.95e-05 | 12 | 74 | 3 | M39611 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 3.23e-05 | 70 | 74 | 5 | M16794 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 3.70e-05 | 72 | 74 | 5 | M9257 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ATP6AP1 SLC24A3 SLC6A15 MCOLN1 SLC1A7 ADD2 SLC8A1 CLCN2 AP2A2 LRRC8B ASIC4 ABCC2 MCOLN2 | 4.77e-05 | 681 | 74 | 13 | MM14985 |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 6.12e-05 | 41 | 74 | 4 | M7399 | |
| Pathway | REACTOME_ASPIRIN_ADME | 8.10e-05 | 44 | 74 | 4 | M45014 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ATP6AP1 SLC24A3 SLC6A15 MCOLN1 SLC1A7 ADD2 SLC8A1 CLCN2 AP2A2 LRRC8B ASIC4 ABCC2 MCOLN2 | 1.05e-04 | 736 | 74 | 13 | M27287 |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 1.57e-04 | 52 | 74 | 4 | M14171 | |
| Pathway | REACTOME_SENSING_OF_DNA_DOUBLE_STRAND_BREAKS | 4.02e-04 | 6 | 74 | 2 | M27585 | |
| Pathway | REACTOME_SENSING_OF_DNA_DOUBLE_STRAND_BREAKS | 4.02e-04 | 6 | 74 | 2 | MM15295 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 4.60e-04 | 29 | 74 | 3 | M45015 | |
| Pathway | REACTOME_MIRO_GTPASE_CYCLE | 5.61e-04 | 7 | 74 | 2 | MM15689 | |
| Pathway | REACTOME_MIRO_GTPASE_CYCLE | 7.46e-04 | 8 | 74 | 2 | M41837 | |
| Pathway | WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME | 9.79e-04 | 145 | 74 | 5 | M45512 | |
| Pathway | REACTOME_RAC2_GTPASE_CYCLE | 1.12e-03 | 87 | 74 | 4 | MM15600 | |
| Pathway | REACTOME_RAC2_GTPASE_CYCLE | 1.17e-03 | 88 | 74 | 4 | M41810 | |
| Pathway | REACTOME_SODIUM_CALCIUM_EXCHANGERS | 1.45e-03 | 11 | 74 | 2 | M27336 | |
| Pubmed | 5.00e-12 | 7 | 106 | 5 | 27514509 | ||
| Pubmed | 4.07e-10 | 5 | 106 | 4 | 20565459 | ||
| Pubmed | 1.22e-09 | 6 | 106 | 4 | 32527940 | ||
| Pubmed | 1.22e-09 | 6 | 106 | 4 | 20297805 | ||
| Pubmed | Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37. | 2.83e-09 | 7 | 106 | 4 | 8467709 | |
| Pubmed | 2.83e-09 | 7 | 106 | 4 | 8464825 | ||
| Pubmed | 5.65e-09 | 8 | 106 | 4 | 20610558 | ||
| Pubmed | 5.65e-09 | 8 | 106 | 4 | 18052087 | ||
| Pubmed | 5.65e-09 | 8 | 106 | 4 | 17179145 | ||
| Pubmed | 1.01e-08 | 9 | 106 | 4 | 22511988 | ||
| Pubmed | 1.69e-08 | 10 | 106 | 4 | 23642732 | ||
| Pubmed | 1.69e-08 | 10 | 106 | 4 | 11465080 | ||
| Pubmed | 1.69e-08 | 10 | 106 | 4 | 23371916 | ||
| Pubmed | A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia. | 1.69e-08 | 10 | 106 | 4 | 22558097 | |
| Pubmed | 2.65e-08 | 11 | 106 | 4 | 18695635 | ||
| Pubmed | 2.75e-08 | 3 | 106 | 3 | 12847094 | ||
| Pubmed | 2.75e-08 | 3 | 106 | 3 | 29519853 | ||
| Pubmed | Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans. | 3.96e-08 | 12 | 106 | 4 | 20308471 | |
| Pubmed | 3.96e-08 | 12 | 106 | 4 | 19419973 | ||
| Pubmed | Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. | 3.96e-08 | 12 | 106 | 4 | 11434514 | |
| Pubmed | UGT1A1 is a major locus influencing bilirubin levels in African Americans. | 5.71e-08 | 13 | 106 | 4 | 22085899 | |
| Pubmed | Genome-wide analysis of hepatic lipid content in extreme obesity. | 5.71e-08 | 13 | 106 | 4 | 25246029 | |
| Pubmed | 7.97e-08 | 14 | 106 | 4 | 21646302 | ||
| Pubmed | Human UDP-glucuronosyltransferases: metabolism, expression, and disease. | 7.97e-08 | 14 | 106 | 4 | 10836148 | |
| Pubmed | 7.97e-08 | 14 | 106 | 4 | 9295054 | ||
| Pubmed | Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation. | 7.97e-08 | 14 | 106 | 4 | 14672974 | |
| Pubmed | 1.10e-07 | 4 | 106 | 3 | 18946804 | ||
| Pubmed | 1.10e-07 | 4 | 106 | 3 | 23700788 | ||
| Pubmed | 1.10e-07 | 4 | 106 | 3 | 20147615 | ||
| Pubmed | 1.10e-07 | 4 | 106 | 3 | 17558305 | ||
| Pubmed | Genome-wide association meta-analysis for total serum bilirubin levels. | 1.44e-07 | 16 | 106 | 4 | 19414484 | |
| Pubmed | Genome-wide association of serum bilirubin levels in Korean population. | 1.88e-07 | 17 | 106 | 4 | 20639394 | |
| Pubmed | 2.41e-07 | 18 | 106 | 4 | 20056724 | ||
| Pubmed | Pharmacokinetics of mycophenolate mofetil and its glucuronide metabolites in healthy volunteers. | 2.74e-07 | 5 | 106 | 3 | 18597651 | |
| Pubmed | 2.74e-07 | 5 | 106 | 3 | 15057901 | ||
| Pubmed | The heteromeric cyclic nucleotide-gated channel adopts a 3A:1B stoichiometry. | 2.74e-07 | 5 | 106 | 3 | 12432397 | |
| Pubmed | A genome-wide assessment of variability in human serum metabolism. | 3.05e-07 | 19 | 106 | 4 | 23281178 | |
| Pubmed | DOCK2 DPP4 PDGFRA MBOAT7 USP9X DOCK10 RHOT2 MELK SLC25A3 PIGT ALG9 HSD11B1 LRBA EXOC7 RHOT1 NCKAP1L | 5.11e-07 | 1168 | 106 | 16 | 19946888 | |
| Pubmed | cGMP and cyclic nucleotide-gated channels participate in mouse sperm capacitation. | 5.47e-07 | 6 | 106 | 3 | 22192355 | |
| Pubmed | Genetic determinants influencing human serum metabolome among African Americans. | 8.26e-07 | 24 | 106 | 4 | 24625756 | |
| Pubmed | Family-based genome-wide association scan of attention-deficit/hyperactivity disorder. | 2.28e-06 | 9 | 106 | 3 | 20732626 | |
| Pubmed | Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. | 3.11e-06 | 203 | 106 | 7 | 16916647 | |
| Pubmed | 3.25e-06 | 10 | 106 | 3 | 16382102 | ||
| Pubmed | 3.44e-06 | 504 | 106 | 10 | 34432599 | ||
| Pubmed | Comprehensive pharmacogenetic analysis of irinotecan neutropenia and pharmacokinetics. | 5.93e-06 | 12 | 106 | 3 | 19349540 | |
| Pubmed | Bidirectional Ca2+-dependent control of mitochondrial dynamics by the Miro GTPase. | 9.20e-06 | 2 | 106 | 2 | 19098100 | |
| Pubmed | Mitochondrial trafficking in neurons and the role of the Miro family of GTPase proteins. | 9.20e-06 | 2 | 106 | 2 | 24256248 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 25540325 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 27732084 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 21321244 | ||
| Pubmed | A role for the Tip60 histone acetyltransferase in the acetylation and activation of ATM. | 9.20e-06 | 2 | 106 | 2 | 16141325 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 31562315 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 20138207 | ||
| Pubmed | Ubiquitin-specific protease activity of USP9Y, a male infertility gene on the Y chromosome. | 9.20e-06 | 2 | 106 | 2 | 12895410 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 11677206 | ||
| Pubmed | The type IV mucolipidosis-associated protein TRPML1 is an endolysosomal iron release channel. | 9.20e-06 | 2 | 106 | 2 | 18794901 | |
| Pubmed | Studies on the substrate specificity of human intestinal UDP- lucuronosyltransferases 1A8 and 1A10. | 9.20e-06 | 2 | 106 | 2 | 10497143 | |
| Pubmed | Huntingtin is a scaffolding protein in the ATM oxidative DNA damage response complex. | 9.20e-06 | 2 | 106 | 2 | 28017939 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 12944498 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 16778789 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 17529886 | ||
| Pubmed | Human Miro Proteins Act as NTP Hydrolases through a Novel, Non-Canonical Catalytic Mechanism. | 9.20e-06 | 2 | 106 | 2 | 30513825 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 8922996 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 24277524 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 7643388 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 25547628 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 36044851 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 12925892 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 12890734 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 11901093 | ||
| Pubmed | Atypical Rho GTPases have roles in mitochondrial homeostasis and apoptosis. | 9.20e-06 | 2 | 106 | 2 | 12482879 | |
| Pubmed | Insight into human Miro1/2 domain organization based on the structure of its N-terminal GTPase. | 9.20e-06 | 2 | 106 | 2 | 33132189 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 16700521 | ||
| Pubmed | The tissue-specific expression of TRPML2 (MCOLN-2) gene is influenced by the presence of TRPML1. | 9.20e-06 | 2 | 106 | 2 | 19763610 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 10444334 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 22031623 | ||
| Pubmed | Miro proteins coordinate microtubule- and actin-dependent mitochondrial transport and distribution. | 9.20e-06 | 2 | 106 | 2 | 29311115 | |
| Pubmed | ATM and KAT5 safeguard replicating chromatin against formaldehyde damage. | 9.20e-06 | 2 | 106 | 2 | 26420831 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 33075816 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 26045217 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 18568343 | ||
| Pubmed | Human UGT1A8 and UGT1A10 mRNA are expressed in primary human hepatocytes. | 9.20e-06 | 2 | 106 | 2 | 17603215 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 15709193 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 9647757 | ||
| Pubmed | RABL2 positively controls localization of GPCRs in mammalian primary cilia. | 9.20e-06 | 2 | 106 | 2 | 30578315 | |
| Pubmed | Synergistic action of DPIV and APN in the regulation of T cell function. | 9.20e-06 | 2 | 106 | 2 | 12675232 | |
| Pubmed | The role of RHOT1 and RHOT2 genetic variation on Parkinson disease risk and onset. | 9.20e-06 | 2 | 106 | 2 | 32948353 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 20089735 | ||
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | TSPAN15 DPY19L3 TMEM120B MBOAT7 VPS13C MCOLN1 ADD2 ALG9 SLC25A13 LRBA ABCC2 | 1.28e-05 | 719 | 106 | 11 | 35337019 |
| Pubmed | 2.66e-05 | 190 | 106 | 6 | 24816252 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 16636344 | ||
| Pubmed | Glucuronidation of psilocin and 4-hydroxyindole by the human UDP-glucuronosyltransferases. | 2.76e-05 | 3 | 106 | 2 | 20007669 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 19244109 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 11379879 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 19885840 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 19225446 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 34406978 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 17406868 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 30994973 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 17924828 | ||
| Cytoband | 2q37 | 8.05e-07 | 31 | 106 | 4 | 2q37 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q37 | 1.87e-04 | 226 | 106 | 5 | chr2q37 | |
| GeneFamily | Cyclic nucleotide gated channels | 8.06e-06 | 10 | 75 | 3 | 250 | |
| GeneFamily | UDP glucuronosyltransferases | 8.99e-06 | 32 | 75 | 4 | 363 | |
| GeneFamily | Miro like atypical Rho GTPases|EF-hand domain containing | 1.70e-05 | 2 | 75 | 2 | 392 | |
| GeneFamily | PRAME family | 1.30e-04 | 24 | 75 | 3 | 686 | |
| GeneFamily | RAB like GTPases | 1.68e-04 | 5 | 75 | 2 | 394 | |
| GeneFamily | Solute carriers | 1.25e-03 | 395 | 75 | 7 | 752 | |
| GeneFamily | Aminopeptidases|CD molecules | 2.22e-03 | 17 | 75 | 2 | 104 | |
| GeneFamily | Transient receptor potential cation channels | 5.99e-03 | 28 | 75 | 2 | 249 | |
| ToppCell | 368C-Myeloid-Macrophage|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.77e-08 | 189 | 106 | 8 | e62355be0d136e2b7c739848022292e9c6af7392 | |
| ToppCell | COVID-19-lung-Macrophage_PPARGhi_CD5Lhi|lung / Disease (COVID-19 only), tissue and cell type | 1.92e-08 | 191 | 106 | 8 | dab953682b8c9ed680a799161f837f792a7e4f33 | |
| ToppCell | COVID-19-lung-Macrophage_PPARGhi_CD5Lhi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.00e-08 | 192 | 106 | 8 | bcfb9c005166bc0b4f8ee2dfc0c1540e8bf0e1ff | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.55e-08 | 198 | 106 | 8 | e125eb8aa57c172e5518874da1bd25998292f5e2 | |
| ToppCell | Nasal_Brush-Immune-Dendritic_cells|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.85e-07 | 183 | 106 | 7 | b1daec831990a53e846c089cebfcf4f8440820e4 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.54e-07 | 189 | 106 | 7 | 7ccea2df93bb4b37417bbc8f6c85a61ece95211a | |
| ToppCell | human_hepatoblastoma-Inflammatory_Monocytes|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.80e-07 | 191 | 106 | 7 | 3b59bfc6c106ae8a3fbcd4a74bd128c485724921 | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)|Adult / Lineage, Cell type, age group and donor | 4.37e-07 | 195 | 106 | 7 | 55e25f702af19146a161861cfd15f40bbda1dc35 | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)-D231|Adult / Lineage, Cell type, age group and donor | 4.85e-07 | 198 | 106 | 7 | 79a415e19cedde13a88f5043d71557363f102322 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 4.85e-07 | 198 | 106 | 7 | af4fb9eb2295c7b90624b38ba25619aa15254efa | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.85e-07 | 198 | 106 | 7 | 0baeb8e2c199ff10bb5c829c523546af3c9227c1 | |
| ToppCell | TCGA-Skin-Metastatic|TCGA-Skin / Sample_Type by Project: Shred V9 | 4.85e-07 | 198 | 106 | 7 | ad39cce004867f083f8da1954e0cf5a263815184 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macro_CHIT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.85e-07 | 198 | 106 | 7 | 0b41b3d6c2db795320e8b65d40d85fb8b618cc34 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 4.85e-07 | 198 | 106 | 7 | 62cbf4b29e8af4983fb47a17f96da62682a5137e | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.01e-07 | 199 | 106 | 7 | 7ee2805fd9143eba11bf6832267b62189683608b | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.19e-07 | 200 | 106 | 7 | 78d75d381cb2b9a4c9eb7c32a07b014eaee39195 | |
| ToppCell | facs-Trachea-3m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_trachea|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.27e-06 | 144 | 106 | 6 | 8bd042f12186f36bc5aabf6a0232270a448f4b58 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-06 | 145 | 106 | 6 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.52e-06 | 162 | 106 | 6 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal-Colon_normal_tissue-Colon_normal_tissue-6|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.52e-06 | 162 | 106 | 6 | 7f9385aa749bfb2fa9fee6939fe46d946bc21d31 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.56e-06 | 172 | 106 | 6 | 3a37569a5902f3c65ff8d3912421309a8c82ee9b | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic-Mast_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.56e-06 | 172 | 106 | 6 | cc9d9dae290f11f8c348c78228af4e49469dc93b | |
| ToppCell | facs-Aorta-Heart-3m-Myeloid|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-06 | 173 | 106 | 6 | 513b4d31bcfb269556c6b4cc389865fb12e52c4f | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.80e-06 | 174 | 106 | 6 | 048febe84566666234bad24c58c28b7e1e2f8381 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.80e-06 | 174 | 106 | 6 | 2afa5eea54b67c549c5058ece98296eee3829c11 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.06e-06 | 176 | 106 | 6 | 926ed37e636fe4dd3a18731cea15761f0c2c285a | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D122|Adult / Lineage, Cell type, age group and donor | 4.06e-06 | 176 | 106 | 6 | 3fee8a367bb9755aca1b7fcc968b08e51b6e9436 | |
| ToppCell | COVID-19-kidney-PCT-S3-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.06e-06 | 176 | 106 | 6 | b6497324e3e52f514ce556a3fa0c3011c45dcc7b | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 4.77e-06 | 181 | 106 | 6 | 88f6f56f5f58b479d5db91b32c45934c045f88ea | |
| ToppCell | facs-Aorta-Heart-3m-Myeloid-macrophage|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.92e-06 | 182 | 106 | 6 | df26388c0c46d1c4775103c8e802937b4d4e7470 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.93e-06 | 188 | 106 | 6 | a244fcd092d5bd544e503366b1439b0fbc1ee00e | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.93e-06 | 188 | 106 | 6 | c8530c9ff98666c64a94683261af4288cb790a7e | |
| ToppCell | Fetal_29-31_weeks-Immune-monocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.30e-06 | 190 | 106 | 6 | ad297172a74a80ed5c10f921e15efd1da0fd2d6b | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.30e-06 | 190 | 106 | 6 | 9b825b2586c7b173ff27fcf2abc5860faf50984a | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.30e-06 | 190 | 106 | 6 | d146af1926474328a7c822bc140c4dda66e1bbfb | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.49e-06 | 191 | 106 | 6 | c72e62cf5b45c04ee5e7719db31f917c4f76b1e4 | |
| ToppCell | (3)_Macrophage_MARCOpos|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.69e-06 | 192 | 106 | 6 | b1e2175bd4c02106e52d8f491eea1329ac327ae9 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.89e-06 | 193 | 106 | 6 | 3e3d7cb3e7242ec9c9677e07e303835649852b52 | |
| ToppCell | RA-08._Macrophage|World / Chamber and Cluster_Paper | 6.89e-06 | 193 | 106 | 6 | 5fd22db1825d105709fcc0aa4955c99a117e3c82 | |
| ToppCell | Fetal_29-31_weeks-Immune-alveolar_macrophage_(MARCO_positive)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.09e-06 | 194 | 106 | 6 | 3043f6230fa723037c8cf7123f611ae847b39fd4 | |
| ToppCell | 356C-Myeloid-Macrophage|356C / Donor, Lineage, Cell class and subclass (all cells) | 7.09e-06 | 194 | 106 | 6 | 3844e6fb43ae2e0a35ea8ccc1a2e11f40b68bc67 | |
| ToppCell | Nasal_Brush-Immune|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.09e-06 | 194 | 106 | 6 | 3135bc4a8112c5dee108e3b8e775f508b65191f1 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.09e-06 | 194 | 106 | 6 | 45708cb2cafde10bf4e4798b81d47c3b1f6aaa14 | |
| ToppCell | RA-08._Macrophage|RA / Chamber and Cluster_Paper | 7.09e-06 | 194 | 106 | 6 | ac26e5c71d5069622de72fa25a9c920887ac2c19 | |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|lung / Disease (COVID-19 only), tissue and cell type | 7.30e-06 | 195 | 106 | 6 | 148fff8c3c9ba45ec36e98dff1be57e3f8294506 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.30e-06 | 195 | 106 | 6 | ce8215d503cad3a9bc7d5d2be4adb57408015593 | |
| ToppCell | human_hepatoblastoma-Inflammatory_Monocytes|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 7.30e-06 | 195 | 106 | 6 | ba7f85e5307d96ac5ad7c952f8d094db9ca1790c | |
| ToppCell | COVID-19-Myeloid-Transitioning_MDM|COVID-19 / group, cell type (main and fine annotations) | 7.52e-06 | 196 | 106 | 6 | 4929cfed1f150c1fde4d79cb49895c2ea467a18f | |
| ToppCell | COVID-19-lung-Macrophage_metabolically_active|lung / Disease (COVID-19 only), tissue and cell type | 7.52e-06 | 196 | 106 | 6 | a753d76d764c181eecb0e17a794a2e7d0ff70136 | |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.52e-06 | 196 | 106 | 6 | 7026c1fc33425e5476063d17c79e4b79356a9e01 | |
| ToppCell | Fetal_29-31_weeks-Immune-monocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.74e-06 | 197 | 106 | 6 | 48a8169a4d33c6a68d66bcd936861c75cb4b60ef | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Dendritic_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.74e-06 | 197 | 106 | 6 | e0fc098bfb5a8b7824ae339f3adda30f78360d0b | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Dendritic_cell-DC_2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.74e-06 | 197 | 106 | 6 | 363ae03310f63a586ba3cea2a59f35d5a335a54e | |
| ToppCell | COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|lung / Disease (COVID-19 only), tissue and cell type | 7.74e-06 | 197 | 106 | 6 | 3896729740d151f0eb845f1961c7b969bfbdd28d | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.74e-06 | 197 | 106 | 6 | d669d90c3f9e98b41bcbc49dbdc5698e0b42597c | |
| ToppCell | Dendritic_cell|World / shred by cell class for turbinate | 7.74e-06 | 197 | 106 | 6 | ab2213e3742f92798922ea318d76328b6ca18b13 | |
| ToppCell | Fetal_29-31_weeks-Immune-alveolar_macrophage_(MARCO_positive)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.97e-06 | 198 | 106 | 6 | ab70bf89690410221ec7aa3149bb50ac34433f99 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Dendritic_cell-DC_2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.97e-06 | 198 | 106 | 6 | d73585a5587941483db8d9ddc2d68f7d852bbbc8 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Mast_cell-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.97e-06 | 198 | 106 | 6 | cc5ca64749e2f4f1d373d9472824df85741702b7 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.97e-06 | 198 | 106 | 6 | d4d66f19df078bfc3a83d4664aaf9c7789bde1a5 | |
| ToppCell | Fetal_29-31_weeks-Immune-alveolar_macrophage_(MARCO_positive)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.20e-06 | 199 | 106 | 6 | 22001aa733273e784051b7f750e07d99aaf7a225 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.20e-06 | 199 | 106 | 6 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Macrophage_other-Macrophage_intermediate|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.44e-06 | 200 | 106 | 6 | 700960201ae0df2c79e2907f5a0f95d73f8034fe | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 8.44e-06 | 200 | 106 | 6 | 6e50272d172b491200d9a255ed08e6d6998cfe02 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 8.44e-06 | 200 | 106 | 6 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 8.44e-06 | 200 | 106 | 6 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.44e-06 | 200 | 106 | 6 | a443e475e7a10c26a6173d1af961de6219e0e567 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_alveolar|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 8.44e-06 | 200 | 106 | 6 | 840be665639a53ba9bafc19f7a81ca1e0436e329 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 8.44e-06 | 200 | 106 | 6 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 8.44e-06 | 200 | 106 | 6 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.44e-06 | 200 | 106 | 6 | 2f5b71e55c2de0e77fdae6667eb57f333acc6cd1 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 8.44e-06 | 200 | 106 | 6 | 310cd53db1c137f6af74e6ae682221d7ac27310c | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.44e-06 | 200 | 106 | 6 | ed785a6d08ca2b350dc3307b587eadfb2886d1f9 | |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 8.44e-06 | 200 | 106 | 6 | 961858738ce35db8760c8c2e136f8369bc444ccf | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD14|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.44e-06 | 200 | 106 | 6 | b4277b6faa69f20974696c7c422311f5c89e3663 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.70e-05 | 147 | 106 | 5 | a5ed71afe5fcb4f541080f5552252695c7d4d090 | |
| ToppCell | 356C-Myeloid-Mast_cell|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.79e-05 | 148 | 106 | 5 | 1668d8a9e680da335362744f36b05446c499347e | |
| ToppCell | 356C-Myeloid-Mast_cell-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.79e-05 | 148 | 106 | 5 | 18511ba10765eda937c5a710626361f7e6b9b321 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_low-phase|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.88e-05 | 149 | 106 | 5 | a6406c4c9404271a2f4c615c6cd3265b2d759b12 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_ductal_cel|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.88e-05 | 149 | 106 | 5 | 7726957b1de638c3bfc659381d15eab626bb179b | |
| ToppCell | E16.5-samps-Myeloid-Fetal_macrophage-Proliferative_Myeloid|E16.5-samps / Age Group, Lineage, Cell class and subclass | 3.17e-05 | 152 | 106 | 5 | e427758a6e39052616a0d8ecec0c1299e81d1d3c | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.70e-05 | 157 | 106 | 5 | ec433d2fe827abdb647be4176c231b7052482b6f | |
| ToppCell | PND07-28-samps|World / Age Group, Lineage, Cell class and subclass | 3.70e-05 | 157 | 106 | 5 | a2005768a6d268879e3fd6dbd8cf674dc98be587 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D122|Adult / Lineage, Cell type, age group and donor | 3.70e-05 | 157 | 106 | 5 | 31d1bd9138c60e8485664ec4144f987226e3eef9 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Adult / Lineage, Cell type, age group and donor | 4.43e-05 | 163 | 106 | 5 | e819a1d6d28290854aa0672b3a18fa9e293d8f23 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.43e-05 | 163 | 106 | 5 | 8dc0128eeede933537e3bcc5d6ec0322711552f3 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.43e-05 | 163 | 106 | 5 | fd243ca223079033be480a24817a399f281fa4d4 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.56e-05 | 164 | 106 | 5 | 6a113191ea91d103d21c5f056b1950217688ea26 | |
| ToppCell | LV-11._Adipocyte|World / Chamber and Cluster_Paper | 4.83e-05 | 166 | 106 | 5 | 7e5852891714465c6228c9f955fd511ec79d0e02 | |
| ToppCell | droplet-Trachea-3m-Hematologic-myeloid-granulocyte-granulocyte_l34|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.11e-05 | 168 | 106 | 5 | 84977db9d71e59208727885320cc18d80d064380 | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_proliferating_1|390C / Donor, Lineage, Cell class and subclass (all cells) | 5.11e-05 | 168 | 106 | 5 | 2082b15fc7935a211f1c61506b305af5501a21ad | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_macrophage-stroma-osteoclast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.11e-05 | 168 | 106 | 5 | 1993e7fb6d7291d448219c813cb968ddad270bb5 | |
| ToppCell | PND07-28-samps-Myeloid|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 5.11e-05 | 168 | 106 | 5 | 87512f9e5e95333e7ffc6efa1e93bab2ba9154c6 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.41e-05 | 170 | 106 | 5 | 71c52fadecc6b4bfe98692b266adaa1406f6d56d | |
| ToppCell | ileum|World / shred on tissue and cell subclass | 5.41e-05 | 170 | 106 | 5 | 9f1211bd4287620e19a59f21e6ecdca3e42e0260 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-9|TCGA-Bladder / Sample_Type by Project: Shred V9 | 5.56e-05 | 171 | 106 | 5 | adbcfa4bf6bc1c604535a24435924cdb091e2dd7 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.56e-05 | 171 | 106 | 5 | 55c7bf7211587fa08df13c0a4ff5b78a85d5439e | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal-Colon_normal_tissue|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 5.71e-05 | 172 | 106 | 5 | 94842346c84542a5243bd765e49f4af8bc5182db | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.71e-05 | 172 | 106 | 5 | ef33b5e0515c6d29fb6d9a673011c1b68ef264f3 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.71e-05 | 172 | 106 | 5 | f6b4754a7e4b3e38030316a0ae00d932bfa87e41 | |
| Drug | naringenin chalcone | 1.97e-09 | 5 | 103 | 4 | ctd:C027329 | |
| Drug | anthrarobin | 1.97e-09 | 5 | 103 | 4 | ctd:C032186 | |
| Drug | 1,2,5,8-tetrahydroxy anthraquinone | 5.88e-09 | 6 | 103 | 4 | ctd:C543211 | |
| Drug | alloin | 5.88e-09 | 6 | 103 | 4 | ctd:C006457 | |
| Drug | 2',5'-dihydroxychalcone | 5.88e-09 | 6 | 103 | 4 | ctd:C107497 | |
| Drug | 2',4'-dihydroxychalcone | 1.37e-08 | 7 | 103 | 4 | ctd:C059354 | |
| Drug | 1,4-dihydroxyanthraquinone | 2.73e-08 | 8 | 103 | 4 | ctd:C034890 | |
| Drug | AC1Q6O8B | 2.93e-08 | 41 | 103 | 6 | CID000000334 | |
| Drug | AC1MRQNQ | 4.89e-08 | 9 | 103 | 4 | CID003522271 | |
| Drug | DHPASiU | 4.89e-08 | 9 | 103 | 4 | CID000197602 | |
| Drug | 3-iodophenol | 4.89e-08 | 9 | 103 | 4 | CID000012272 | |
| Drug | AC1L4J7U | 4.89e-08 | 9 | 103 | 4 | CID000186631 | |
| Drug | Chebi:32663 | 4.89e-08 | 9 | 103 | 4 | CID005460873 | |
| Drug | estradiol-3-glucuronide | 5.42e-08 | 23 | 103 | 5 | CID000066651 | |
| Drug | 2,6-dihydroxyanthraquinone | 8.12e-08 | 10 | 103 | 4 | ctd:C034889 | |
| Drug | N-phenylmaleimide | 8.49e-08 | 25 | 103 | 5 | CID000013662 | |
| Drug | campestrol | 8.84e-08 | 49 | 103 | 6 | CID000010134 | |
| Drug | 4-nitrophenyl)imidazole | 1.27e-07 | 11 | 103 | 4 | CID000123155 | |
| Drug | AC1O5XMV | 1.27e-07 | 11 | 103 | 4 | CID006442661 | |
| Drug | erucin | 1.55e-07 | 28 | 103 | 5 | CID000078160 | |
| Drug | H-Ni | 1.55e-07 | 28 | 103 | 5 | CID000445665 | |
| Drug | AC1L1JAL | 1.87e-07 | 29 | 103 | 5 | CID000004954 | |
| Drug | N-OH-DABZ | 1.90e-07 | 12 | 103 | 4 | CID000051366 | |
| Drug | 1-O-beta-D-glucopyranosyl-D-mannitol | 1.90e-07 | 12 | 103 | 4 | CID000088735 | |
| Drug | 4-hydroxyestrone | 1.90e-07 | 12 | 103 | 4 | ctd:C026418 | |
| Drug | 2,4,6-TCB | 1.90e-07 | 12 | 103 | 4 | CID000037247 | |
| Drug | nonanoyl-N-methylglucamide | 1.90e-07 | 12 | 103 | 4 | CID000160090 | |
| Drug | 7,7,7-triphenylheptanoic acid | 1.90e-07 | 12 | 103 | 4 | CID000276709 | |
| Drug | AC1L9E0Q | 2.24e-07 | 30 | 103 | 5 | CID000443095 | |
| Drug | dihydroartemisinin | 2.24e-07 | 30 | 103 | 5 | CID000107770 | |
| Drug | 2-hydroxyestrone | 2.74e-07 | 13 | 103 | 4 | ctd:C024980 | |
| Drug | tritanol | 2.74e-07 | 13 | 103 | 4 | CID000006457 | |
| Drug | 5-azido-UDP-glucuronic acid | 2.74e-07 | 13 | 103 | 4 | CID003081279 | |
| Drug | cotinine-N-glucuronide | 2.74e-07 | 13 | 103 | 4 | CID000000411 | |
| Drug | alizarin | 2.74e-07 | 13 | 103 | 4 | ctd:C010078 | |
| Drug | NNAL | 3.14e-07 | 32 | 103 | 5 | CID000104856 | |
| Drug | hydratropic acid | 3.58e-07 | 4 | 103 | 3 | ctd:C013025 | |
| Drug | 2-vanillin | 3.58e-07 | 4 | 103 | 3 | ctd:C060843 | |
| Drug | diphenylacetic acid | 3.58e-07 | 4 | 103 | 3 | ctd:C037760 | |
| Drug | propranolol glucuronide | 3.82e-07 | 14 | 103 | 4 | CID000119515 | |
| Drug | PCB-61 | 3.82e-07 | 14 | 103 | 4 | CID000036401 | |
| Drug | 3-[(3S,5R,10S,13R,14S,17R)-3-[(2S,4R,5R,6S)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one | 5.01e-07 | 35 | 103 | 5 | CID010436171 | |
| Drug | 2,2',3,5,5'-pentachlorobiphenyl | 5.19e-07 | 15 | 103 | 4 | CID000040469 | |
| Drug | afloqualone | 5.19e-07 | 15 | 103 | 4 | CID000002040 | |
| Drug | naphthyl sulphate | 5.19e-07 | 15 | 103 | 4 | CID000114775 | |
| Drug | coumarin-3-carboxylic acid | 5.19e-07 | 15 | 103 | 4 | CID000010752 | |
| Drug | bergamottin | 5.19e-07 | 15 | 103 | 4 | ctd:C068337 | |
| Drug | sulforaphane nitrile | 5.19e-07 | 15 | 103 | 4 | CID000543743 | |
| Drug | muraglitazar | 5.79e-07 | 36 | 103 | 5 | CID000206044 | |
| Drug | pregnenolone-16 alpha-carbonitrile | 5.91e-07 | 67 | 103 | 6 | CID000015032 | |
| Drug | quercetin-3,4'-diglucoside | 6.89e-07 | 16 | 103 | 4 | CID005320835 | |
| Drug | 1'-hydroxyestragole | 6.89e-07 | 16 | 103 | 4 | CID000040003 | |
| Drug | bilirubin-phosphate | 6.89e-07 | 16 | 103 | 4 | CID005497144 | |
| Drug | formononetin | 7.66e-07 | 38 | 103 | 5 | ctd:C007768 | |
| Drug | 4-methylumbelliferyl glucuronide | 7.66e-07 | 38 | 103 | 5 | CID000091553 | |
| Drug | isovaleric acid | 8.93e-07 | 5 | 103 | 3 | ctd:C008216 | |
| Drug | biphenylylacetic acid | 8.93e-07 | 5 | 103 | 3 | ctd:C012776 | |
| Drug | 3 beta,5 alpha,25R)- 3-hydroxyspirostan-12-one | 8.98e-07 | 17 | 103 | 4 | CID000003573 | |
| Drug | 6-hydroxychrysene | 8.98e-07 | 17 | 103 | 4 | CID000037766 | |
| Drug | eugenol | 9.85e-07 | 73 | 103 | 6 | CID000003314 | |
| Drug | harmol | 9.97e-07 | 40 | 103 | 5 | CID000068094 | |
| Drug | SureCN12722713 | 1.15e-06 | 18 | 103 | 4 | CID005488034 | |
| Drug | ethyl-beta-D-6-glucosiduronic acid | 1.15e-06 | 18 | 103 | 4 | CID000152226 | |
| Drug | Br 2 | 1.15e-06 | 18 | 103 | 4 | CID003060900 | |
| Drug | 2,3,7-trichlorodibenzo-p-dioxin | 1.15e-06 | 18 | 103 | 4 | CID000036614 | |
| Drug | ApApG | 1.15e-06 | 18 | 103 | 4 | CID003081975 | |
| Drug | C1 11-32 | 1.15e-06 | 18 | 103 | 4 | CID000443077 | |
| Drug | C11131 | 1.15e-06 | 18 | 103 | 4 | CID000443076 | |
| Drug | AC1NFJIQ | 1.28e-06 | 42 | 103 | 5 | CID004659568 | |
| Drug | 9-OH-risperidone | 1.45e-06 | 19 | 103 | 4 | CID000475100 | |
| Drug | 5alpha-spirostan-3beta-ol | 1.45e-06 | 19 | 103 | 4 | CID000091433 | |
| Drug | almokalant | 1.45e-06 | 19 | 103 | 4 | CID003033962 | |
| Drug | 3-phenylpropionic acid | 1.78e-06 | 6 | 103 | 3 | ctd:C035253 | |
| Drug | Indoprofen | 1.78e-06 | 6 | 103 | 3 | ctd:D007216 | |
| Drug | tectochrysin | 1.81e-06 | 20 | 103 | 4 | CID005281954 | |
| Drug | AC1L1OBF | 1.81e-06 | 20 | 103 | 4 | CID000032736 | |
| Drug | 4'-hydroxydiclofenac | 1.81e-06 | 20 | 103 | 4 | CID000116545 | |
| Drug | entacapone | 1.81e-06 | 20 | 103 | 4 | ctd:C071192 | |
| Drug | estriol-16-glucuronide | 2.23e-06 | 21 | 103 | 4 | CID000122281 | |
| Drug | dulcin | 2.23e-06 | 21 | 103 | 4 | CID000009013 | |
| Drug | Benzamidoxime hydrochloride | 2.23e-06 | 21 | 103 | 4 | CID000069186 | |
| Drug | 5 alpha-androstane | 2.26e-06 | 84 | 103 | 6 | CID000094144 | |
| Drug | diosmetin | 2.42e-06 | 85 | 103 | 6 | CID005281612 | |
| Drug | salicylamide | 2.52e-06 | 48 | 103 | 5 | CID000005147 | |
| Drug | retigabine | 2.52e-06 | 48 | 103 | 5 | CID000121892 | |
| Drug | amonafide | 2.71e-06 | 22 | 103 | 4 | CID000050515 | |
| Drug | N-methylpiperazine | 2.71e-06 | 22 | 103 | 4 | CID000053167 | |
| Drug | plumbagin | 2.71e-06 | 22 | 103 | 4 | ctd:C014758 | |
| Drug | N6-methyladenosine [1867-73-8]; Up 200; 14.2uM; PC3; HT_HG-U133A | 2.76e-06 | 193 | 103 | 8 | 6732_UP | |
| Drug | biochanin A | 2.78e-06 | 87 | 103 | 6 | ctd:C004541 | |
| Drug | amidoxime | 3.27e-06 | 23 | 103 | 4 | CID000465967 | |
| Drug | phenanthridine | 3.27e-06 | 23 | 103 | 4 | CID000009189 | |
| Drug | C2-MPAcid | 3.42e-06 | 51 | 103 | 5 | CID000508230 | |
| Drug | AC1NQGK1 | 3.77e-06 | 52 | 103 | 5 | CID005195977 | |
| Drug | AS-3201 | 3.91e-06 | 24 | 103 | 4 | CID000153948 | |
| Drug | 2-naphthol | 4.10e-06 | 93 | 103 | 6 | CID000008663 | |
| Drug | ASA404 | 4.15e-06 | 53 | 103 | 5 | CID000123964 | |
| Drug | HCG 004 | 4.56e-06 | 54 | 103 | 5 | CID000064928 | |
| Drug | tangeretin | 4.56e-06 | 54 | 103 | 5 | CID000068077 | |
| Drug | Equol | 4.56e-06 | 54 | 103 | 5 | ctd:D060754 | |
| Disease | N-acetyl-4-chlorophenylalanine measurement | 5.70e-10 | 5 | 98 | 4 | EFO_0801060 | |
| Disease | 5-hydroxyindole sulfate measurement | 5.70e-10 | 5 | 98 | 4 | EFO_0800085 | |
| Disease | nuclear receptor subfamily 1 group D member 2 measurement | 5.70e-10 | 5 | 98 | 4 | EFO_0801853 | |
| Disease | 3-carboxy-4-methyl-5-pentyl-2-furanpropionate (3-CMPFP) measurement | 1.71e-09 | 6 | 98 | 4 | EFO_0800566 | |
| Disease | X-21441 measurement | 2.19e-09 | 17 | 98 | 5 | EFO_0800814 | |
| Disease | X-21339 measurement | 3.97e-09 | 7 | 98 | 4 | EFO_0800808 | |
| Disease | X-11793--oxidized bilirubin measurement | 7.93e-09 | 8 | 98 | 4 | EFO_0021260 | |
| Disease | Succinimide measurement | 7.93e-09 | 8 | 98 | 4 | EFO_0022118 | |
| Disease | X-11530 measurement | 7.93e-09 | 8 | 98 | 4 | EFO_0021249 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 7.93e-09 | 8 | 98 | 4 | EFO_0801034 | |
| Disease | cholelithiasis, bilirubin measurement | 7.93e-09 | 8 | 98 | 4 | EFO_0004570, EFO_0004799 | |
| Disease | X-11522 measurement | 7.93e-09 | 8 | 98 | 4 | EFO_0800696 | |
| Disease | X-10458 measurement | 7.93e-09 | 8 | 98 | 4 | EFO_0800692 | |
| Disease | X-24849 measurement | 7.93e-09 | 8 | 98 | 4 | EFO_0800909 | |
| Disease | serum N-desmethylclozapine measurement | 7.93e-09 | 8 | 98 | 4 | EFO_0600043 | |
| Disease | plasma clozapine measurement | 7.93e-09 | 8 | 98 | 4 | EFO_0600038 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 7.93e-09 | 8 | 98 | 4 | EFO_0802740 | |
| Disease | X-16946 measurement | 7.93e-09 | 8 | 98 | 4 | EFO_0800766 | |
| Disease | X-11442 measurement | 1.42e-08 | 9 | 98 | 4 | EFO_0021236 | |
| Disease | X-11441 measurement | 1.42e-08 | 9 | 98 | 4 | EFO_0021235 | |
| Disease | circulating cell free DNA measurement | 1.42e-08 | 9 | 98 | 4 | EFO_0004739 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 1.42e-08 | 9 | 98 | 4 | EFO_0801037 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 1.42e-08 | 9 | 98 | 4 | EFO_0802127 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 1.42e-08 | 9 | 98 | 4 | EFO_0801036 | |
| Disease | X-11880 measurement | 1.42e-08 | 9 | 98 | 4 | EFO_0800698 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 1.42e-08 | 9 | 98 | 4 | EFO_0004570, GO_0009410 | |
| Disease | protein-tyrosine kinase 6 measurement | 1.42e-08 | 9 | 98 | 4 | EFO_0020691 | |
| Disease | X-21448 measurement | 2.37e-08 | 10 | 98 | 4 | EFO_0800816 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 2.37e-08 | 10 | 98 | 4 | EFO_0802185 | |
| Disease | X-23974 measurement | 2.37e-08 | 10 | 98 | 4 | EFO_0800867 | |
| Disease | bilirubin measurement, response to tenofovir | 2.37e-08 | 10 | 98 | 4 | EFO_0004570, EFO_0009279 | |
| Disease | blood 4-oxo-retinoic acid measurement | 3.55e-08 | 3 | 98 | 3 | EFO_0022216 | |
| Disease | indole-3-carboxylate measurement | 3.55e-08 | 3 | 98 | 3 | EFO_0800043 | |
| Disease | X-21796 measurement | 3.71e-08 | 11 | 98 | 4 | EFO_0800825 | |
| Disease | pregnenetriol sulfate measurement | 3.71e-08 | 11 | 98 | 4 | EFO_0800586 | |
| Disease | plasma N-desmethylclozapine measurement | 3.71e-08 | 11 | 98 | 4 | EFO_0600039 | |
| Disease | insomnia, bilirubin measurement | 3.71e-08 | 11 | 98 | 4 | EFO_0004570, EFO_0004698 | |
| Disease | histidine betaine (hercynine) measurement | 3.71e-08 | 11 | 98 | 4 | EFO_0800972 | |
| Disease | aldosterone measurement | 3.71e-08 | 11 | 98 | 4 | EFO_0010219 | |
| Disease | biliverdin measurement | 5.55e-08 | 12 | 98 | 4 | EFO_0021033 | |
| Disease | p-cresol glucuronide measurement | 5.55e-08 | 12 | 98 | 4 | EFO_0800079 | |
| Disease | X-24588 measurement | 7.99e-08 | 13 | 98 | 4 | EFO_0800898 | |
| Disease | retinol dehydrogenase 16 measurement | 7.99e-08 | 13 | 98 | 4 | EFO_0802007 | |
| Disease | pregnenetriol disulfate measurement | 7.99e-08 | 13 | 98 | 4 | EFO_0800587 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 2.63e-07 | 17 | 98 | 4 | EFO_0004611, EFO_0007800 | |
| Disease | angiopoietin-related protein 1 measurement | 3.38e-07 | 18 | 98 | 4 | EFO_0801382 | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 6.25e-07 | 147 | 98 | 7 | DOID:9352 (biomarker_via_orthology) | |
| Disease | tissue factor measurement | 6.56e-07 | 21 | 98 | 4 | EFO_0010623 | |
| Disease | urate measurement, spine bone mineral density | 1.45e-06 | 58 | 98 | 5 | EFO_0004531, EFO_0007701 | |
| Disease | gallstones | 1.67e-06 | 108 | 98 | 6 | EFO_0004210 | |
| Disease | neuroblastoma, cutaneous melanoma | 2.20e-06 | 28 | 98 | 4 | EFO_0000389, EFO_0000621 | |
| Disease | xanthurenate measurement | 2.55e-06 | 29 | 98 | 4 | EFO_0010551 | |
| Disease | response to dolutegravir | 2.93e-06 | 30 | 98 | 4 | EFO_0600017 | |
| Disease | indoleacetate measurement | 4.19e-06 | 10 | 98 | 3 | EFO_0021015 | |
| Disease | vitamin D deficiency | 6.95e-06 | 37 | 98 | 4 | EFO_0003762 | |
| Disease | thyroxine measurement | 8.62e-06 | 83 | 98 | 5 | EFO_0005130 | |
| Disease | hormone measurement | 9.14e-06 | 84 | 98 | 5 | EFO_0004730 | |
| Disease | cholelithiasis | 1.15e-05 | 88 | 98 | 5 | EFO_0004799 | |
| Disease | vitamin D measurement, COVID-19 | 2.16e-05 | 49 | 98 | 4 | EFO_0004631, MONDO_0100096 | |
| Disease | mucolipidosis type IV (implicated_via_orthology) | 3.27e-05 | 3 | 98 | 2 | DOID:0080490 (implicated_via_orthology) | |
| Disease | glycoproteinosis (implicated_via_orthology) | 6.52e-05 | 4 | 98 | 2 | DOID:3343 (implicated_via_orthology) | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 1.26e-04 | 145 | 98 | 5 | DOID:1289 (implicated_via_orthology) | |
| Disease | HWESASXX measurement | 2.27e-04 | 7 | 98 | 2 | EFO_0021147 | |
| Disease | Osteochondritis dissecans | 2.27e-04 | 7 | 98 | 2 | HP_0010886 | |
| Disease | status epilepticus (biomarker_via_orthology) | 3.51e-04 | 100 | 98 | 4 | DOID:1824 (biomarker_via_orthology) | |
| Disease | peptidyl-glycine alpha-amidating monooxygenase measurement | 5.89e-04 | 11 | 98 | 2 | EFO_0801871 | |
| Disease | lignoceroylcarnitine (C24) measurement | 5.89e-04 | 11 | 98 | 2 | EFO_0800541 | |
| Disease | corpus callosum posterior volume measurement | 6.98e-04 | 52 | 98 | 3 | EFO_0010298 | |
| Disease | dodecanedioate measurement | 7.05e-04 | 12 | 98 | 2 | EFO_0021054 | |
| Disease | congenital disorder of glycosylation type I (implicated_via_orthology) | 1.11e-03 | 15 | 98 | 2 | DOID:0050570 (implicated_via_orthology) | |
| Disease | peritonsillar abscess | 1.61e-03 | 18 | 98 | 2 | EFO_0007429 | |
| Disease | nucleotide measurement | 1.87e-03 | 73 | 98 | 3 | EFO_0010513 | |
| Disease | selenium measurement, response to dietary selenium supplementation | 2.00e-03 | 20 | 98 | 2 | EFO_0006331, EFO_0600021 | |
| Disease | seminoma (is_marker_for) | 2.42e-03 | 22 | 98 | 2 | DOID:4440 (is_marker_for) | |
| Disease | frailty measurement | 2.64e-03 | 23 | 98 | 2 | EFO_0009885 | |
| Disease | metabolite measurement | 2.67e-03 | 560 | 98 | 7 | EFO_0004725 | |
| Disease | response to antidepressant | 2.86e-03 | 176 | 98 | 4 | GO_0036276 | |
| Disease | Glioma | 3.08e-03 | 87 | 98 | 3 | C0017638 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TYISTKLTRYLNWIG | 56 | P16118 | |
| TSTYWLTRIQSFLYC | 396 | Q76B58 | |
| SLRYLTWRATLYTAV | 286 | Q96N23 | |
| LIERYQRLYTWTQAV | 311 | Q400G9 | |
| ALITLAVVYAALWRY | 891 | O60242 | |
| RQSVLQIYTSWIFYS | 161 | Q6ZNB7 | |
| YRLEHYTVTSNWLAL | 401 | Q9H6U8 | |
| AASIAYISRILWLYF | 161 | Q96IZ2 | |
| YWTRDLQRISSYSLE | 271 | Q8IV13 | |
| KELWILNRYLSYTLN | 836 | P15144 | |
| LQAIYVTALYITSWL | 166 | Q6ZPD9 | |
| YRQTVCLSLLWRIYS | 1206 | Q96PN6 | |
| YLLKRLNLIWNIYST | 751 | Q6Q4G3 | |
| LRQEEVYYDSSLWTT | 251 | P28845 | |
| VYYDSSLWTTLLIRN | 256 | P28845 | |
| AVTSYKRYLWATVTI | 1386 | Q8IZT6 | |
| VDYTWYVDTILNLIR | 436 | O94973 | |
| RSSLVWLFSQLYLYS | 486 | Q9GZU1 | |
| SLWQYDHLTATYLLL | 306 | Q14680 | |
| KVTYRNLSTWYTELR | 106 | Q9UBK7 | |
| KVTYRNLSTWYTELR | 106 | Q9UNT1 | |
| LYTTLSDVWSYGILL | 871 | P16234 | |
| LSLLWLLYYVASTTR | 131 | Q7RTS5 | |
| NTYLWRTSLYLAASA | 156 | Q00325 | |
| QRLLDFIYTAWLSLS | 81 | Q8N239 | |
| LFQTDTRIYLLAYWS | 291 | Q9UPQ8 | |
| TRIYLLAYWSLLATL | 296 | Q9UPQ8 | |
| YSYAWILGSISTVSL | 501 | Q9UPQ8 | |
| WYQKRLSTTSRLLIY | 56 | A0A075B6J2 | |
| SYNITRLLQATEYWA | 581 | O75325 | |
| SIWKLEYILTQTYDI | 366 | Q92484 | |
| LLSYRSYWSQTILEI | 411 | Q92993 | |
| WTGIALLYLQLYRVT | 106 | Q9NS86 | |
| WTLTTYLDVQRCLEY | 366 | Q8IXI2 | |
| YKTRSSSYLDNLVWR | 446 | Q16659 | |
| SSDSYIGLWRNYLIL | 856 | O94915 | |
| IYLLYLQDLWTTVID | 46 | Q99712 | |
| TTLYTNWYLESLLRQ | 786 | P55160 | |
| WLKNRTLDEYLTYLL | 156 | P0DUQ1 | |
| YILSGSRDATLLLWY | 2656 | P50851 | |
| LLSLADTLRYWASIY | 416 | Q96N66 | |
| NTYRLKLYSLRWISD | 51 | P27487 | |
| LSSITYSWYDSIILK | 201 | Q92887 | |
| YLYSRTEIGQWSITS | 381 | Q96KJ4 | |
| LTLLEILDYIYEVSW | 456 | Q96FT7 | |
| NYSYEKLLWTTSRVL | 321 | P14923 | |
| VALSSWCLLRDSIYY | 206 | Q9HC58 | |
| WCLLRDSIYYTLSVI | 211 | Q9HC58 | |
| IQTYQRSWLKVTDYI | 616 | Q9UPT5 | |
| ILVILYGLTSSYSLW | 321 | Q6P9F7 | |
| SLYTNWYLETLLRQV | 786 | Q9Y2A7 | |
| LQSWLYSSRLLQYSD | 131 | O95299 | |
| TRYTILYASRKAWIA | 851 | Q2VWP7 | |
| YISLALGSYSSWSRV | 646 | Q9UHC9 | |
| TKWRSILYNLYDLLV | 306 | Q13315 | |
| TIAISTDYWLYTRAL | 36 | Q8WXS5 | |
| SRRTQYFYSWLLNVL | 281 | P42858 | |
| YLPTSLADYILTRSW | 296 | O14756 | |
| LEYLYLDSTTRSWRK | 61 | Q8WZ79 | |
| KTISYETLIAYWQRA | 1346 | Q96BY6 | |
| NYTEAAYTLLLHTWL | 1236 | Q92608 | |
| TWVLVATSLVLLYIY | 11 | Q9HB55 | |
| SRLGVLTVAYYLWTT | 86 | O00341 | |
| LYLLLFWLSGYSIVT | 6 | Q8TDQ1 | |
| WTVAIALYLYLSIVR | 96 | Q5UAW9 | |
| LTWLAVTLLTGTYYE | 116 | Q5JW98 | |
| LVQYLKWRSATVVYD | 166 | Q13003 | |
| SILVWLFSRLYLYSF | 476 | Q8IZK6 | |
| SVIETVNSYYDILWS | 1421 | Q8TE73 | |
| LVRSISNSYSYIWIG | 91 | Q6UW15 | |
| YSVELRITSYNAWVV | 76 | P59544 | |
| TVLSELLWQVAYSYT | 2316 | Q93008 | |
| YWYREALNISSSISE | 206 | Q9H2J7 | |
| WYYCTLTIRESILIS | 166 | A0PK00 | |
| YLCQWTLVTYLDVRS | 361 | Q8IXI1 | |
| TLTLVESNYYWTSVT | 91 | Q9NXP7 | |
| SRIWYLYLQNNLIET | 71 | O60938 | |
| LWNSYFLASILRYTI | 216 | Q86SK9 | |
| WLKNRTLDEYLTYLL | 156 | A3QJZ7 | |
| YYDLINFTWINSRTV | 401 | Q8N3P4 | |
| QSYIPYRDSVLTWLL | 331 | Q9P2P6 | |
| SILWTLTNYLYLLAL | 256 | A4IF30 | |
| LYGWAQLSDTYVTLR | 146 | P35612 | |
| TLLTYELLQRWFYID | 596 | Q9UJS0 | |
| VYSLYWSTLTLTTIG | 346 | P29973 | |
| LVAWLVLDYTSDLLY | 66 | Q8IV77 | |
| DSYTDRLYLLWLLLV | 211 | Q9NQW8 | |
| LNTSILLQYLAWVTY | 126 | P51788 | |
| IYLIDWIFTLYSKSL | 581 | Q9P2M4 | |
| RALVSILQSWYTLFT | 901 | Q9P217 | |
| AYDLYSHTSIWLLRT | 241 | Q9HAW8 | |
| WYLRLYVHTLTITSK | 391 | Q969N2 | |
| IQRYSSYWRITSIKE | 181 | Q9HAI6 | |
| DIYSYAVITWEVLSR | 211 | O43353 | |
| WLKNRTLDEYLTYLL | 156 | P0DUQ2 | |
| SYLWLKFSLIIYSTV | 16 | O95858 | |
| FTLTLQLWLTYYLGL | 106 | Q7L0L9 | |
| SGYLISDLSIIILYW | 96 | Q96MV1 | |
| IYKLIRLDSLSAYWN | 246 | Q709C8 | |
| LYWTTLYSVESTRLN | 801 | P08922 | |
| VLSWNEYSIYLLDTV | 301 | O15040 | |
| VDWYAVSTLTTYLQE | 136 | Q15904 | |
| STVLSELLWQVAYSY | 2316 | O00507 | |
| EYDLYSHTSIWLLRT | 241 | O60656 | |
| LVTSSVDTYIYIWDI | 121 | Q6PJI9 | |
| AYDLYSHTSIWLLRT | 241 | Q9HAW7 | |
| AYDLYSHTSIWLLRT | 241 | Q9HAW9 | |
| SSEWLYRVTVATILY | 256 | Q9H6D3 | |
| YSVVLAIDSYWSTSL | 441 | Q9NS93 | |
| AIDSYWSTSLSYITL | 446 | Q9NS93 | |
| LTVQSYNTVTRQWLY | 416 | Q9P2K6 | |
| SIFAYTWLYIILSVI | 211 | P32418 |